戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 target for potential drug therapies to treat muscle pain.
2 y systemic symptoms such as fever, bone, and muscle pain.
3 els of peripheral neuropathy to evaluate for muscle pain.
4 nd transient, mild lower-extremity edema and muscle pain.
5 ot appear to modulate acute exercise-induced muscle pain.
6 nd was free of muscle weakness, and bone and muscle pain.
7 y accepted as a causal mechanism for chronic muscle pain.
8 d fever (temperature >38.5 degrees C), 7 had muscle pain, 6 had sinusitis, and 6 had biopsy evidence
9  (1832 [25.4%]), fatigue (1361 [18.9%]), and muscle pain (942 [13.1%]) were the most commonly reporte
10 al underlying reasons for the comorbidity of muscle pain and altered sympathetic reflexes in disease
11 usible that this finding partly explains the muscle pain and exercise intolerance that many patients
12  development of alternative therapeutics for muscle pain and may be especially relevant to pain cause
13                                              Muscle pain and weakness are the cardinal symptoms and o
14    Recovery occurred within 24 hrs, although muscle pain and weakness persisted for 2 months after st
15 wn statin-like lowering of LDL-C without the muscle pain and weakness responsible for discontinuation
16 the frequency of less-serious events such as muscle pain and weakness, which may affect 1% to 5% of p
17 derate levels of experimental sustained deep muscle pain, and a baseline, control state.
18 A prevalent side effect of statin therapy is muscle pain, and yet the basic mechanism behind it remai
19   Many clinicians believe that statins cause muscle pain, but this has not been observed in clinical
20 le of the cAMP pathway in a model of chronic muscle pain by assessing associated behavioral changes a
21 resolve within a few days, chronic joint and muscle pain can be long lasting.
22 was found at the ankle and on the arm during muscle pain compared to the control condition.
23 e TA muscle were found during saline-induced muscle pain compared to the infusion of isotonic saline.
24 ns in blood flow/oxygenation and a number of muscle pain disorders are based in problems of periphera
25  central command modulates the perception of muscle pain during exercise.
26 nemius muscle strongly enhanced acid-induced muscle pain in mice that was abolished by genetic inacti
27  bubble gum for 6 min) increases masticatory muscle pain in patients, but not in asymptomatic control
28  males and seven females, with no history of muscle pain in the masticatory system participated in th
29 ), headache (in 25.1% and 31.9%, vs. 16.9%), muscle pain (in 22.3% and 26.9%, vs. 13.3%), feverishnes
30 t study was to determine if exercise-induced muscle pain is modulated by central neural mechanisms (i
31 ults support the suggestion that neuropathic muscle pain may be a greater clinical problem than gener
32 ce for the involvement of Vi in craniofacial muscle pain mechanisms.
33  Evidence of muscle disease was indicated by muscle pain, muscle weakness and wasting, significant fa
34 -myo-neuropathy," characterized by joint and muscle pains, muscle fatigue, difficulty lifting, and ex
35 s, the placebo-corrected incidences of minor muscle pain, myopathy (with significant elevations in cr
36                   The effect of experimental muscle pain on the amplitude and velocity sensitivity of
37 fects of the statin-are myopathy (defined as muscle pain or weakness combined with large increases in
38                                    Myopathy--muscle pain or weakness with blood creatine kinase level
39 py may cause symptomatic adverse events (eg, muscle pain or weakness) in up to about 50-100 patients
40 ay result in widespread deep hyperalgesia in muscle pain patients.
41                                   Ratings of muscle pain perception (MPP) and perceived exertion (RPE
42  with symptoms that include severe joint and muscle pain, rashes, and fever, as well as prolonged per
43  afferent function, leading to modulation of muscle pain-related behaviors and EPRs after BAO.
44 ll described in skeletal muscle, neuropathic muscle pain remains to be clarified.
45               Nonetheless, the role of SP in muscle pain remains unknown.
46 ponse pattern may be associated with chronic muscle pain states.
47 were neutropenia (38 [35%] of 110 patients), muscle pain (ten [9%]), rash (eight [7%]), cough, dyspno
48                               The ability of muscle pain to generate somatosensory sensibility change
49              The inhibitory mechanism during muscle pain was shown to be effective for the deep tissu
50          Because chewing-induced masticatory muscle pain was significantly greater in female control
51       Mild cold exacerbation and significant muscle pain were equally common features in dominant and
52  hyperalgesia, and susceptibility to chronic muscle pain, which is unveiled by exposure to stress in
53 sh, fever episodes, arthralgia, and bone and muscle pain with cryopyrin-associated periodic syndromes
54  purposes, such as the fever, skin diseases, muscle pains, wounds and stomach problems.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。